glp 1 thanksgiving How to Navigate the Holidays on GLP-1 Medication: Physician How to Do Thanksgiving on

Second cardiovascular safety trial to demonstrate that a GLP-1R agonist reduces MACE and microvascular (including renal) events in patients with T2DM and high cardiovascular risk

By week 8, most clinical trial participants had lost 5 to 8 pounds cumulatively, with the rate of loss accelerating as they adjusted to the medication's effects and their bodies adapted to lower food consumption

For patients with chronic kidney disease, heart failure, or established atherosclerotic cardiovascular disease, substituting a sodium-glucose cotransporter 2 (SGLT2) inhibitor may be preferred

doi: 10.3748/wjg.v24.i30.3361 128 AnguloPKleinerDEDam-LarsenSAdamsLABjornssonESCharatcharoenwitthayaPet al

What are GLP-1 medications for weight loss